KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Capital Expenditures: 2017-2025

Historic Capital Expenditures for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $28.0 million.

  • Twist Bioscience's Capital Expenditures rose 520.73% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 451.69%. This contributed to the annual value of $28.0 million for FY2025, which is 451.69% up from last year.
  • Latest data reveals that Twist Bioscience reported Capital Expenditures of $28.0 million as of FY2025, which was up 451.69% from $5.1 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Capital Expenditures ranged from a high of $101.9 million in FY2022 and a low of $5.1 million during FY2024.
  • Moreover, its 3-year median value for Capital Expenditures was $27.8 million (2023), whereas its average is $20.3 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 81.73% in 2024, then soared by 451.69% in 2025.
  • Over the past 5 years, Twist Bioscience's Capital Expenditures (Yearly) stood at $27.1 million in 2021, then soared by 276.40% to $101.9 million in 2022, then plummeted by 72.73% to $27.8 million in 2023, then plummeted by 81.73% to $5.1 million in 2024, then spiked by 451.69% to $28.0 million in 2025.